These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 16785196)

  • 1. Circadian rhythm of fasting and postprandial portal blood flow in cirrhosis.
    Schiedermaier P; Koch L; Mojón A; Hermida R; Layer G; Sauerbruch T
    Scand J Gastroenterol; 2006 Jul; 41(7):826-32. PubMed ID: 16785196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of propranolol and depot lanreotide SR on postprandial and circadian portal haemodynamics in cirrhosis.
    Schiedermaier P; Koch L; Stoffel-Wagner B; Layer G; Sauerbruch T
    Aliment Pharmacol Ther; 2003 Oct; 18(8):777-84. PubMed ID: 14535870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute hemodynamic effects of octreotide and terlipressin in patients with cirrhosis: a randomized comparison.
    Baik SK; Jeong PH; Ji SW; Yoo BS; Kim HS; Lee DK; Kwon SO; Kim YJ; Park JW; Chang SJ; Lee SS
    Am J Gastroenterol; 2005 Mar; 100(3):631-5. PubMed ID: 15743362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The extent of the collateral circulation influences the postprandial increase in portal pressure in patients with cirrhosis.
    Albillos A; Bañares R; González M; Catalina MV; Pastor O; Gonzalez R; Ripoll C; Bosch J
    Gut; 2007 Feb; 56(2):259-64. PubMed ID: 16837532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ascorbic acid improves the intrahepatic endothelial dysfunction of patients with cirrhosis and portal hypertension.
    Hernández-Guerra M; García-Pagán JC; Turnes J; Bellot P; Deulofeu R; Abraldes JG; Bosch J
    Hepatology; 2006 Mar; 43(3):485-91. PubMed ID: 16496307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
    Abraldes JG; Albillos A; Bañares R; Turnes J; González R; García-Pagán JC; Bosch J
    Gastroenterology; 2009 May; 136(5):1651-8. PubMed ID: 19208350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postprandial effects of dark chocolate on portal hypertension in patients with cirrhosis: results of a phase 2, double-blind, randomized controlled trial.
    De Gottardi A; Berzigotti A; Seijo S; D'Amico M; Thormann W; Abraldes JG; García-Pagán JC; Bosch J
    Am J Clin Nutr; 2012 Sep; 96(3):584-90. PubMed ID: 22811444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 3-month course of long-acting repeatable octreotide (sandostatin LAR) improves portal hypertension in patients with cirrhosis: a randomized controlled study.
    Spahr L; Giostra E; Frossard JL; Morard I; Mentha G; Hadengue A
    Am J Gastroenterol; 2007 Jul; 102(7):1397-405. PubMed ID: 17488248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Measurement of hepatic venous pressure gradient in liver cirrhosis: relationship with the status of cirrhosis, varices, and ascites in Korea].
    Kim MY; Baik SK; Suk KT; Yea CJ; Lee IY; Kim JW; Cha SH; Kim YJ; Um SH; Han KH
    Korean J Hepatol; 2008 Jun; 14(2):150-8. PubMed ID: 18617762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of hepatic arterial flow on portal venous and hepatic venous wedged pressure in the isolated perfused CCl4-cirrhotic liver.
    Zipprich A; Loureiro-Silva MR; D'Silva I; Groszmann RJ
    Am J Physiol Gastrointest Liver Physiol; 2008 Jul; 295(1):G197-G202. PubMed ID: 18497333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic venous pressure gradient does not correlate with the presence and the severity of portal hypertensive gastropathy in patients with liver cirrhosis.
    Bellis L; Nicodemo S; Galossi A; Guarisco R; Spilabotti L; Durola L; Dell'Unto O; Puoti C
    J Gastrointestin Liver Dis; 2007 Sep; 16(3):273-7. PubMed ID: 17925921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered basal and postprandial plasma melatonin, gastrin, ghrelin, leptin and insulin in patients with liver cirrhosis and portal hypertension without and with oral administration of melatonin or tryptophan.
    Celinski K; Konturek PC; Slomka M; Cichoz-Lach H; Gonciarz M; Bielanski W; Reiter RJ; Konturek SJ
    J Pineal Res; 2009 May; 46(4):408-14. PubMed ID: 19552764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between diurnal blood pressure variation and diurnal blood glucose levels in type 2 diabetic patients.
    Pistrosch F; Reissmann E; Wildbrett J; Koehler C; Hanefeld M
    Am J Hypertens; 2007 May; 20(5):541-5. PubMed ID: 17485018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of eating, rumination, and arterial pressure in determination of the circadian rhythm of renal blood flow in sheep.
    Tebot I; Bonnet JM; Junot S; Ayoub JY; Paquet C; Cirio A
    J Anim Sci; 2009 Feb; 87(2):554-61. PubMed ID: 18849386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of hepatic venous pressure gradient for in-hospital mortality of patients with severe acute alcoholic hepatitis.
    Rincon D; Lo Iacono O; Ripoll C; Gomez-Camarero J; Salcedo M; Catalina MV; Hernando A; Clemente G; Matilla A; Nuñez O; Bañares R
    Aliment Pharmacol Ther; 2007 Apr; 25(7):841-8. PubMed ID: 17373923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The changes of hepatic hemodynamics and functional hepatic reserve after splenectomy with periesophagogastric devascularization.
    Zhang Y; Wen T; Yan L; Chen Z; Yang H; Deng X; Liang G; Li G; Zhang X; Ran S; Liao Z
    Hepatogastroenterology; 2009; 56(91-92):835-9. PubMed ID: 19621712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic venous pressure gradient as a predictor of fibrosis in chronic liver disease because of hepatitis B virus.
    Kumar M; Kumar A; Hissar S; Jain P; Rastogi A; Kumar D; Sakhuja P; Sarin SK
    Liver Int; 2008 May; 28(5):690-8. PubMed ID: 18433395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upright posture blunts postprandial splanchnic hyperemia in patients with cirrhosis and portal hypertension.
    Iwao T; Oho K; Nakano R; Yamawaki M; Sakai T; Sato M; Miyamoto Y; Sakai K; Sata M; Toyonaga A
    J Gastroenterol; 1999 Jun; 34(3):359-65. PubMed ID: 10433012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis.
    Lemoine M; Katsahian S; Ziol M; Nahon P; Ganne-Carrie N; Kazemi F; Grando-Lemaire V; Trinchet JC; Beaugrand M
    Aliment Pharmacol Ther; 2008 Nov; 28(9):1102-10. PubMed ID: 18691352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic fat content is a determinant of postprandial triglyceride levels in type 2 diabetes mellitus patients with normal fasting triglyceride.
    Nimitphong H; Phongkitkarun S; Rattarasarn C; Kongsooksai A; Chanprasertyothin S; Bunnag PA; Puavilai G
    Metabolism; 2008 May; 57(5):644-9. PubMed ID: 18442627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.